Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy

被引:12
作者
Arranja, A. G. [1 ,2 ,3 ]
Hennink, W. E. [1 ]
Chassagne, C. [4 ]
Denkova, A. G. [2 ]
Nijsen, J. F. W. [3 ,5 ]
机构
[1] Univ Utrecht, Fac Sci, Dept Pharmaceut, UIPS,Sci Life, NL-3508 TB Utrecht, Netherlands
[2] Delft Univ Technol, Radiat Sci & Technol, Mekelweg 15, NL-2629 JB Delft, Netherlands
[3] Radboudumc, Dept Radiol & Nucl Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[4] Delft Univ Technol, Dept Hydraul Engn, Stevinweg 1, NL-2628 CN Delft, Netherlands
[5] Quirem Med BV, Zutphenseweg 55, NL-7418 AH Deventer, Netherlands
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2020年 / 106卷
关键词
Microspheres; Holmium phosphate; Holmium hydroxide; Radionuclide therapy; Neutron activation; Hemocompatibility; POLY(L-LACTIC ACID) MICROSPHERES; LIVER-TUMORS; INTRATUMORAL INJECTION; LOADED MICROSPHERES; NEUTRON-ACTIVATION; RADIATION-THERAPY; RADIOEMBOLIZATION; CANCER; BRACHYTHERAPY; METASTASES;
D O I
10.1016/j.msec.2019.110244
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Microspheres with high specific activities of radionuclides are very interesting for internal radiotherapy treatments. This work focuses on the formulation and characterization of inorganic microspheres with a high content of holmium and therefore a high specific radioactivity of holmium-166. Two novel formulations of inorganic microspheres were obtained by dispersing solid holmium acetylacetonate microspheres (Ho-2(AcAc)(3)-ms) in NaH2PO4 or NaOH solutions followed by 2 h incubation at room temperature. By exchange of acetylacetonate with phosphate or hydroxyl ions, holmium phosphate microspheres (HoPO4-ms) and holmium hydroxide microspheres (Ho(OH)(3)-ms) were formed respectively. The inorganic microspheres had a significantly smaller diameter (28.5 +/- 4.4 mu m (HoPO4-ms) and 25.1 +/- 3.5 mu m (Ho(OH)(3)-ms)) than those of Ho-2(AcAc)(3)-ms (32.6 +/- 5.2 mu m). The weight percentage of holmium-165 in the microspheres increased significantly from 47% (Ho-2(AcAc)(3)-ms) to 55% (HoPO4-ms) and 73% (Ho(OH)(3)-ms). After preparation of both HoPO4-ms and Ho (OH)(3)-ms, the stable holmium -165 isotope was partly converted by neutron activation into radioactive holmium-166 to yield radioactive microspheres. High specific activities were achieved ranging from 21.7 to 59.9 MBq/mg ((HoPO4)-Ho-166-ms) and from 28.8 to 79.9 MBq/mg (Ho-166(OH)(3)-ms) depending on the neutron activation time. The structure of both microspheres was preserved up to neutron activations of 6 h in a thermal neutron flux of 4.72 x 10(16) n m(-2) s(-1). After activation, both microspheres revealed excellent stability in administration fluids (saline and phosphate buffer) having less than 0.05% of holmium released after 72 h incubation. Finally, the hemocompatibility of these inorganic microspheres was evaluated and it was shown that the microspheres did cause neither hemolysis nor depletion or inhibition of the coagulation factors of the intrinsic blood coagulation pathway meaning that the microspheres have a good hemocompatibility. Overall, this work shows that radioactive inorganic microspheres with high specific activities of holmium-166 can be prepared which potentially can be used for internal radionuclide therapy.
引用
收藏
页数:11
相关论文
共 65 条
[1]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[2]   REGIONAL DELIVERY OF MICROSPHERES TO LIVER METASTASES - THE EFFECTS OF PARTICLE-SIZE AND CONCENTRATION ON INTRAHEPATIC DISTRIBUTION [J].
ANDERSON, JH ;
ANGERSON, WJ ;
WILLMOTT, N ;
KERR, DJ ;
MCARDLE, CS ;
COOKE, TG .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1031-1034
[3]   Radioactive holmium phosphate microspheres for cancer treatment [J].
Arranja, A. G. ;
Hennink, W. E. ;
Denkova, A. G. ;
Hendrikx, R. W. A. ;
Nijsen, J. F. W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 548 (01) :73-81
[4]   Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use [J].
Bakker, Robbert C. ;
van Es, Robert J. J. ;
Rosenberg, Antoine J. W. P. ;
van Nimwegen, Sebastiaan A. ;
Bastiaannet, Remco ;
de Jong, Hugo W. A. M. ;
Nijsen, Johannes F. W. ;
Lam, Marnix G. E. H. .
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (03) :213-221
[5]  
Bakker RC, 2017, J RADIOL ONCOL, V6, P323, DOI 10.1007/s13566-017-0315-6
[6]   Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes [J].
Boas, F. Edward ;
Bodei, Lisa ;
Sofocleous, Constantinos T. .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 :104S-111S
[7]  
BRAAT A, 2016, J NUCL MED S2, V57
[8]   Microspheres with Ultrahigh Holmium Content for Radioablation of Malignancies [J].
Bult, W. ;
Seevinck, P. R. ;
Krijger, G. C. ;
Visser, T. ;
Kroon-Batenburg, L. M. J. ;
Bakker, C. J. G. ;
Hennink, W. E. ;
van het Schip, A. D. ;
Nijsen, J. F. W. .
PHARMACEUTICAL RESEARCH, 2009, 26 (06) :1371-1378
[9]  
Bult W., 2007, patent number EP, Patent No. [07112807.8, 071128078]
[10]   Radioactive Holmium Acetylacetonate Microspheres for Interstitial Microbrachytherapy: An In Vitro and In Vivo Stability Study [J].
Bult, Wouter ;
de Leeuw, Hendrik ;
Steinebach, Olav M. ;
van der Bom, Martijn J. ;
Wolterbeek, Hubert Th. ;
Heeren, Ron M. A. ;
Bakker, Chris J. G. ;
Schip, Alfred D. van Het ;
Hennink, Wim E. ;
Nijsen, J. Frank W. .
PHARMACEUTICAL RESEARCH, 2012, 29 (03) :827-836